Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 953 entries
Sorted by: Best Match Show Resources per page
[Psychology for nurses. 3. Subconscious and aspiration].

Kangogaku zasshi

Takagi T.
PMID: 4960529
Kangogaku Zasshi. 1966 Dec;30(12):93-6.

No abstract available.

Cite
Takagi T. [Psychology for nurses. 3. Subconscious and aspiration]. Kangogaku Zasshi. 1966;30(12):93-6
Takagi, T. (1966). [Psychology for nurses. 3. Subconscious and aspiration]. Kangogaku zasshi, 30(12), 93-6.
Takagi, T. "[Psychology for nurses. 3. Subconscious and aspiration]." Kangogaku zasshi vol. 30,12 (1966): 93-6.
Takagi T. [Psychology for nurses. 3. Subconscious and aspiration]. Kangogaku Zasshi. 1966 Dec;30(12):93-6. Japanese. PMID: 4960529.
Copy Download .nbib Format: NLM
Saphenous neuropathy in a patient with low back pain.

Journal of brachial plexus and peripheral nerve injury

Ahadi T, Raissi GR, Togha M, Nejati P.
PMID: 20205890
J Brachial Plex Peripher Nerve Inj. 2010 Jan 16;5:2. doi: 10.1186/1749-7221-5-2.

Saphenous nerve, a pure sensory nerve, may compromise as a result or complication of a surgical procedure or secondary to trauma or insidiously. We present a male patient with low back pain concomitant with pain in medial portion of...

Cite
Ahadi T, Raissi GR, Togha M, et al. Saphenous neuropathy in a patient with low back pain. J Brachial Plex Peripher Nerve Inj. 2010;5:2doi: 10.1186/1749-7221-5-2.
Ahadi, T., Raissi, G. R., Togha, M., & Nejati, P. (2010). Saphenous neuropathy in a patient with low back pain. Journal of brachial plexus and peripheral nerve injury, 52. https://doi.org/10.1186/1749-7221-5-2
Ahadi, Tannaz, et al. "Saphenous neuropathy in a patient with low back pain." Journal of brachial plexus and peripheral nerve injury vol. 5 (2010): 2. doi: https://doi.org/10.1186/1749-7221-5-2
Ahadi T, Raissi GR, Togha M, Nejati P. Saphenous neuropathy in a patient with low back pain. J Brachial Plex Peripher Nerve Inj. 2010 Jan 16;5:2. doi: 10.1186/1749-7221-5-2. PMID: 20205890; PMCID: PMC2827394.
Copy Download .nbib Format: NLM
Long-term survival of a patient with small cell carcinoma of the stomach with metachronous lung metastases treated by multimodal therapy: a case report.

Surgical case reports

Aoyagi K, Kizaki J, Isobe T, Akagi Y.
PMID: 26943449
Surg Case Rep. 2015 Dec;1(1):125. doi: 10.1186/s40792-015-0126-1. Epub 2015 Dec 24.

A 69-year-old man was referred to our institution for treatment of gastric cancer. Type 2 gastric cancer was found on the anterior wall of the lower body of the stomach.The patient underwent distal gastrectomy, D2 lymph node dissection, and...

Cite
Aoyagi K, Kizaki J, Isobe T, et al. Long-term survival of a patient with small cell carcinoma of the stomach with metachronous lung metastases treated by multimodal therapy: a case report. Surg Case Rep. 2015;1(1):125doi: 10.1186/s40792-015-0126-1.
Aoyagi, K., Kizaki, J., Isobe, T., & Akagi, Y. (2015). Long-term survival of a patient with small cell carcinoma of the stomach with metachronous lung metastases treated by multimodal therapy: a case report. Surgical case reports, 1(1), 125. https://doi.org/10.1186/s40792-015-0126-1
Aoyagi, Keishiro, et al. "Long-term survival of a patient with small cell carcinoma of the stomach with metachronous lung metastases treated by multimodal therapy: a case report." Surgical case reports vol. 1,1 (2015): 125. doi: https://doi.org/10.1186/s40792-015-0126-1
Aoyagi K, Kizaki J, Isobe T, Akagi Y. Long-term survival of a patient with small cell carcinoma of the stomach with metachronous lung metastases treated by multimodal therapy: a case report. Surg Case Rep. 2015 Dec;1(1):125. doi: 10.1186/s40792-015-0126-1. Epub 2015 Dec 24. PMID: 26943449; PMCID: PMC4690825.
Copy Download .nbib Format: NLM
Muscle Shear Moduli Changes and Frequency of Alternate Muscle Activity of Plantar Flexor Synergists Induced by Prolonged Low-Level Contraction.

Frontiers in physiology

Akagi R, Fukui T, Kubota M, Nakamura M, Ema R.
PMID: 28979212
Front Physiol. 2017 Sep 20;8:708. doi: 10.3389/fphys.2017.00708. eCollection 2017.

During prolonged low-level contractions, synergist muscles are activated in an alternating pattern of activity and silence called as alternate muscle activity. Resting muscle stiffness is considered to increase due to muscle fatigue. Thus, we investigated whether the difference in...

Cite
Akagi R, Fukui T, Kubota M, et al. Muscle Shear Moduli Changes and Frequency of Alternate Muscle Activity of Plantar Flexor Synergists Induced by Prolonged Low-Level Contraction. Front Physiol. 2017;8:708doi: 10.3389/fphys.2017.00708.
Akagi, R., Fukui, T., Kubota, M., Nakamura, M., & Ema, R. (2017). Muscle Shear Moduli Changes and Frequency of Alternate Muscle Activity of Plantar Flexor Synergists Induced by Prolonged Low-Level Contraction. Frontiers in physiology, 8708. https://doi.org/10.3389/fphys.2017.00708
Akagi, Ryota, et al. "Muscle Shear Moduli Changes and Frequency of Alternate Muscle Activity of Plantar Flexor Synergists Induced by Prolonged Low-Level Contraction." Frontiers in physiology vol. 8 (2017): 708. doi: https://doi.org/10.3389/fphys.2017.00708
Akagi R, Fukui T, Kubota M, Nakamura M, Ema R. Muscle Shear Moduli Changes and Frequency of Alternate Muscle Activity of Plantar Flexor Synergists Induced by Prolonged Low-Level Contraction. Front Physiol. 2017 Sep 20;8:708. doi: 10.3389/fphys.2017.00708. eCollection 2017. PMID: 28979212; PMCID: PMC5611407.
Copy Download .nbib Format: NLM
Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report.

Molecular and clinical oncology

Nishimura S, Hashimoto K, Tan A, Yagyu Y, Akagi M.
PMID: 28451403
Mol Clin Oncol. 2017 Mar;6(3):307-310. doi: 10.3892/mco.2017.1137. Epub 2017 Jan 23.

Giant cell tumor of bone (GCTB) is commonly treated with surgery; however, surgery of GCTB in the sacrum may be challenging due to the associated risk. A conservative approach may be selective arterial embolization or zoledronic acid (ZOL) treatment;...

Cite
Nishimura S, Hashimoto K, Tan A, et al. Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report. Mol Clin Oncol. 2017;6(3):307-310doi: 10.3892/mco.2017.1137.
Nishimura, S., Hashimoto, K., Tan, A., Yagyu, Y., & Akagi, M. (2017). Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report. Molecular and clinical oncology, 6(3), 307-310. https://doi.org/10.3892/mco.2017.1137
Nishimura, Shunji, et al. "Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report." Molecular and clinical oncology vol. 6,3 (2017): 307-310. doi: https://doi.org/10.3892/mco.2017.1137
Nishimura S, Hashimoto K, Tan A, Yagyu Y, Akagi M. Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report. Mol Clin Oncol. 2017 Mar;6(3):307-310. doi: 10.3892/mco.2017.1137. Epub 2017 Jan 23. PMID: 28451403; PMCID: PMC5403697.
Copy Download .nbib Format: NLM
Study of Perfluoroalkyl Chain-Specific Band Shift in Infrared Spectra on the Chain Length.

The journal of physical chemistry. A

Shimoaka T, Sonoyama M, Amii H, Takagi T, Kanamori T, Hasegawa T.
PMID: 28981281
J Phys Chem A. 2017 Nov 09;121(44):8425-8431. doi: 10.1021/acs.jpca.7b08940. Epub 2017 Oct 25.

The CF

Cite
Shimoaka T, Sonoyama M, Amii H, et al. Study of Perfluoroalkyl Chain-Specific Band Shift in Infrared Spectra on the Chain Length. J Phys Chem A. 2017;121(44):8425-8431doi: 10.1021/acs.jpca.7b08940.
Shimoaka, T., Sonoyama, M., Amii, H., Takagi, T., Kanamori, T., & Hasegawa, T. (2017). Study of Perfluoroalkyl Chain-Specific Band Shift in Infrared Spectra on the Chain Length. The journal of physical chemistry. A, 121(44), 8425-8431. https://doi.org/10.1021/acs.jpca.7b08940
Shimoaka, Takafumi, et al. "Study of Perfluoroalkyl Chain-Specific Band Shift in Infrared Spectra on the Chain Length." The journal of physical chemistry. A vol. 121,44 (2017): 8425-8431. doi: https://doi.org/10.1021/acs.jpca.7b08940
Shimoaka T, Sonoyama M, Amii H, Takagi T, Kanamori T, Hasegawa T. Study of Perfluoroalkyl Chain-Specific Band Shift in Infrared Spectra on the Chain Length. J Phys Chem A. 2017 Nov 09;121(44):8425-8431. doi: 10.1021/acs.jpca.7b08940. Epub 2017 Oct 25. PMID: 28981281.
Copy Download .nbib Format: NLM
Successful treatment with s-1 and oxaliplatin combination therapy in an elderly patient with metastatic colorectal cancer initially presenting with membranous nephropathy.

Case reports in oncology

Matsunaga M, Miwa K, Oka Y, Ushijima T, Yuge K, Fukahori M, Katagiri M, Akagi Y.
PMID: 26034482
Case Rep Oncol. 2015 Apr 28;8(1):212-6. doi: 10.1159/000382119. eCollection 2015.

The incidence, morbidity, and mortality of colorectal cancer are increasing, largely owing to an increasingly aging population. Additionally, along with the increasing age of cancer patients, the number of patients with various comorbidities such as membranous nephropathy is also...

Cite
Matsunaga M, Miwa K, Oka Y, et al. Successful treatment with s-1 and oxaliplatin combination therapy in an elderly patient with metastatic colorectal cancer initially presenting with membranous nephropathy. Case Rep Oncol. 2015;8(1):212-6doi: 10.1159/000382119.
Matsunaga, M., Miwa, K., Oka, Y., Ushijima, T., Yuge, K., Fukahori, M., Katagiri, M., & Akagi, Y. (2015). Successful treatment with s-1 and oxaliplatin combination therapy in an elderly patient with metastatic colorectal cancer initially presenting with membranous nephropathy. Case reports in oncology, 8(1), 212-6. https://doi.org/10.1159/000382119
Matsunaga, Mototsugu, et al. "Successful treatment with s-1 and oxaliplatin combination therapy in an elderly patient with metastatic colorectal cancer initially presenting with membranous nephropathy." Case reports in oncology vol. 8,1 (2015): 212-6. doi: https://doi.org/10.1159/000382119
Matsunaga M, Miwa K, Oka Y, Ushijima T, Yuge K, Fukahori M, Katagiri M, Akagi Y. Successful treatment with s-1 and oxaliplatin combination therapy in an elderly patient with metastatic colorectal cancer initially presenting with membranous nephropathy. Case Rep Oncol. 2015 Apr 28;8(1):212-6. doi: 10.1159/000382119. eCollection 2015. PMID: 26034482; PMCID: PMC4448055.
Copy Download .nbib Format: NLM
Tubular adenoma of the common bile duct with uptake in .

Molecular and clinical oncology

Hokonohara K, Noda T, Hatano H, Takata A, Hirota M, Oshima K, Tanida T, Komori T, Morita S, Imamura H, Iwazawa T, Akagi K, Hayashi S, Inada M, Adachi S, Dono K.
PMID: 26870353
Mol Clin Oncol. 2016 Jan;4(1):35-38. doi: 10.3892/mco.2015.676. Epub 2015 Nov 09.

A 64-year-old man presented with epigastric discomfort and nausea. Laboratory analyses revealed increased levels of total and direct bilirubin, and increased levels of aminotransferases. Computed tomography revealed the presence of a mass in the distal common bile duct. Endoscopic...

Cite
Hokonohara K, Noda T, Hatano H, et al. Tubular adenoma of the common bile duct with uptake in . Mol Clin Oncol. 2015;4(1):35-38doi: 10.3892/mco.2015.676.
Hokonohara, K., Noda, T., Hatano, H., Takata, A., Hirota, M., Oshima, K., Tanida, T., Komori, T., Morita, S., Imamura, H., Iwazawa, T., Akagi, K., Hayashi, S., Inada, M., Adachi, S., & Dono, K. (2016). Tubular adenoma of the common bile duct with uptake in . Molecular and clinical oncology, 4(1), 35-38. https://doi.org/10.3892/mco.2015.676
Hokonohara, Kentaro, et al. "Tubular adenoma of the common bile duct with uptake in ." Molecular and clinical oncology vol. 4,1 (2016): 35-38. doi: https://doi.org/10.3892/mco.2015.676
Hokonohara K, Noda T, Hatano H, Takata A, Hirota M, Oshima K, Tanida T, Komori T, Morita S, Imamura H, Iwazawa T, Akagi K, Hayashi S, Inada M, Adachi S, Dono K. Tubular adenoma of the common bile duct with uptake in . Mol Clin Oncol. 2016 Jan;4(1):35-38. doi: 10.3892/mco.2015.676. Epub 2015 Nov 09. PMID: 26870353; PMCID: PMC4727081.
Copy Download .nbib Format: NLM
Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer.

Oncology letters

Suzuki R, Takagi T, Hikichi T, Konno N, Sugimoto M, Watanabe KO, Nakamura J, Waragai Y, Kikuchi H, Takasumi M, Watanabe H, Ohira H.
PMID: 27123132
Oncol Lett. 2016 May;11(5):3441-3445. doi: 10.3892/ol.2016.4381. Epub 2016 Mar 29.

As gemcitabine is a key anti-tumor agent for unresectable pancreatic ductal adenocarcinoma (PDAC), it is important to predict the outcomes of gemcitabine chemotherapy. The present study aimed to confirm whether the derived neutrophil-to-lymphocyte ratio (dNLR) is able to predict...

Cite
Suzuki R, Takagi T, Hikichi T, et al. Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer. Oncol Lett. 2016;11(5):3441-3445doi: 10.3892/ol.2016.4381.
Suzuki, R., Takagi, T., Hikichi, T., Konno, N., Sugimoto, M., Watanabe, K. O., Nakamura, J., Waragai, Y., Kikuchi, H., Takasumi, M., Watanabe, H., & Ohira, H. (2016). Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer. Oncology letters, 11(5), 3441-3445. https://doi.org/10.3892/ol.2016.4381
Suzuki, Rei, et al. "Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer." Oncology letters vol. 11,5 (2016): 3441-3445. doi: https://doi.org/10.3892/ol.2016.4381
Suzuki R, Takagi T, Hikichi T, Konno N, Sugimoto M, Watanabe KO, Nakamura J, Waragai Y, Kikuchi H, Takasumi M, Watanabe H, Ohira H. Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer. Oncol Lett. 2016 May;11(5):3441-3445. doi: 10.3892/ol.2016.4381. Epub 2016 Mar 29. PMID: 27123132; PMCID: PMC4840986.
Copy Download .nbib Format: NLM
Suspension Arthroplasty Combined with Ligament Reconstruction of the Thumb Carpometacarpal Joint to Salvage Two Failed Arthroplasties: A Case Report.

Journal of orthopaedic case reports

Kakinoki R, Hashimoto K, Tanaka H, Akagi M.
PMID: 28630840
J Orthop Case Rep. 2017 Jan-Feb;7(1):50-53. doi: 10.13107/jocr.2250-0685.684.

INTRODUCTION: Thumb basal joint arthroplasty with removal of the entire trapezium is often followed by proximal subsidence and impingement of the thumb metacarpal to the scaphoid, which is a common cause of post-operative thumb pain. Treatment of this impingement...

Cite
Kakinoki R, Hashimoto K, Tanaka H, et al. Suspension Arthroplasty Combined with Ligament Reconstruction of the Thumb Carpometacarpal Joint to Salvage Two Failed Arthroplasties: A Case Report. J Orthop Case Rep. 2017;7(1):50-53doi: 10.13107/jocr.2250-0685.684.
Kakinoki, R., Hashimoto, K., Tanaka, H., & Akagi, M. (2017). Suspension Arthroplasty Combined with Ligament Reconstruction of the Thumb Carpometacarpal Joint to Salvage Two Failed Arthroplasties: A Case Report. Journal of orthopaedic case reports, 7(1), 50-53. https://doi.org/10.13107/jocr.2250-0685.684
Kakinoki, Ryosuke, et al. "Suspension Arthroplasty Combined with Ligament Reconstruction of the Thumb Carpometacarpal Joint to Salvage Two Failed Arthroplasties: A Case Report." Journal of orthopaedic case reports vol. 7,1 (2017): 50-53. doi: https://doi.org/10.13107/jocr.2250-0685.684
Kakinoki R, Hashimoto K, Tanaka H, Akagi M. Suspension Arthroplasty Combined with Ligament Reconstruction of the Thumb Carpometacarpal Joint to Salvage Two Failed Arthroplasties: A Case Report. J Orthop Case Rep. 2017 Jan-Feb;7(1):50-53. doi: 10.13107/jocr.2250-0685.684. PMID: 28630840; PMCID: PMC5458698.
Copy Download .nbib Format: NLM
Clinical and functional characterization of the Pro1198Leu ABCC8 gene mutation associated with permanent neonatal diabetes mellitus.

Journal of diabetes investigation

Takagi T, Furuta H, Miyawaki M, Nagashima K, Shimada T, Doi A, Matsuno S, Tanaka D, Nishi M, Sasaki H, Inagaki N, Yoshikawa N, Nanjo K, Akamizu T.
PMID: 24843665
J Diabetes Investig. 2013 May 06;4(3):269-73. doi: 10.1111/jdi.12049. Epub 2013 Mar 11.

AIMS/INTRODUCTION: The adenosine triphosphate (ATP)-sensitive potassium (KATP) channel is a key component of insulin secretion in pancreatic β-cells. Activating mutations in ABCC8 encoding for the sulfonylurea receptor subunit of the KATP channel have been associated with the development of...

Cite
Takagi T, Furuta H, Miyawaki M, et al. Clinical and functional characterization of the Pro1198Leu ABCC8 gene mutation associated with permanent neonatal diabetes mellitus. J Diabetes Investig. 2013;4(3):269-73doi: 10.1111/jdi.12049.
Takagi, T., Furuta, H., Miyawaki, M., Nagashima, K., Shimada, T., Doi, A., Matsuno, S., Tanaka, D., Nishi, M., Sasaki, H., Inagaki, N., Yoshikawa, N., Nanjo, K., & Akamizu, T. (2013). Clinical and functional characterization of the Pro1198Leu ABCC8 gene mutation associated with permanent neonatal diabetes mellitus. Journal of diabetes investigation, 4(3), 269-73. https://doi.org/10.1111/jdi.12049
Takagi, Tomoyuki, et al. "Clinical and functional characterization of the Pro1198Leu ABCC8 gene mutation associated with permanent neonatal diabetes mellitus." Journal of diabetes investigation vol. 4,3 (2013): 269-73. doi: https://doi.org/10.1111/jdi.12049
Takagi T, Furuta H, Miyawaki M, Nagashima K, Shimada T, Doi A, Matsuno S, Tanaka D, Nishi M, Sasaki H, Inagaki N, Yoshikawa N, Nanjo K, Akamizu T. Clinical and functional characterization of the Pro1198Leu ABCC8 gene mutation associated with permanent neonatal diabetes mellitus. J Diabetes Investig. 2013 May 06;4(3):269-73. doi: 10.1111/jdi.12049. Epub 2013 Mar 11. PMID: 24843665; PMCID: PMC4015663.
Copy Download .nbib Format: NLM
Implementation of tetra-poly(ethylene glycol) hydrogel with high mechanical strength into microfluidic device technology.

Biomicrofluidics

Takehara H, Nagaoka A, Noguchi J, Akagi T, Sakai T, Chung UI, Kasai H, Ichiki T.
PMID: 24404072
Biomicrofluidics. 2013 Sep 23;7(5):54109. doi: 10.1063/1.4822033. eCollection 2013.

Hydrogels have several excellent characteristics suitable for biomedical use such as softness, biological inertness and solute permeability. Hence, integrating hydrogels into microfluidic devices is a promising approach for providing additional functions such as biocompatibility and porosity, to microfluidic devices....

Cite
Takehara H, Nagaoka A, Noguchi J, et al. Implementation of tetra-poly(ethylene glycol) hydrogel with high mechanical strength into microfluidic device technology. Biomicrofluidics. 2013;7(5):54109doi: 10.1063/1.4822033.
Takehara, H., Nagaoka, A., Noguchi, J., Akagi, T., Sakai, T., Chung, U. I., Kasai, H., & Ichiki, T. (2013). Implementation of tetra-poly(ethylene glycol) hydrogel with high mechanical strength into microfluidic device technology. Biomicrofluidics, 7(5), 54109. https://doi.org/10.1063/1.4822033
Takehara, Hiroaki, et al. "Implementation of tetra-poly(ethylene glycol) hydrogel with high mechanical strength into microfluidic device technology." Biomicrofluidics vol. 7,5 (2013): 54109. doi: https://doi.org/10.1063/1.4822033
Takehara H, Nagaoka A, Noguchi J, Akagi T, Sakai T, Chung UI, Kasai H, Ichiki T. Implementation of tetra-poly(ethylene glycol) hydrogel with high mechanical strength into microfluidic device technology. Biomicrofluidics. 2013 Sep 23;7(5):54109. doi: 10.1063/1.4822033. eCollection 2013. PMID: 24404072; PMCID: PMC3795735.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 953 entries